125 related articles for article (PubMed ID: 23070593)
21. The application of Apc
Ren J; Sui H; Fang F; Li Q; Li B
J Cancer Res Clin Oncol; 2019 May; 145(5):1111-1122. PubMed ID: 30887153
[TBL] [Abstract][Full Text] [Related]
22. The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease.
Sieber OM; Tomlinson IP; Lamlum H
Mol Med Today; 2000 Dec; 6(12):462-9. PubMed ID: 11099951
[TBL] [Abstract][Full Text] [Related]
23. Robust statistical methods for analysis of biomarkers measured with batch/experiment-specific errors.
Long Q; Flanders WD; Fedirko V; Bostick RM
Stat Med; 2010 Feb; 29(3):361-70. PubMed ID: 20020422
[TBL] [Abstract][Full Text] [Related]
24. Reproducibility of parameter learning with missing observations in naive Wnt Bayesian network trained on colorectal cancer samples and doxycycline-treated cell lines.
Sinha S
Mol Biosyst; 2015 Jul; 11(7):1802-19. PubMed ID: 25961654
[TBL] [Abstract][Full Text] [Related]
25. Effects of vitamin D and calcium on expression of MSH2 and transforming growth factors in normal-appearing colorectal mucosa of sporadic colorectal adenoma patients: A randomized clinical trial.
Kwan AK; Um CY; Rutherford RE; Seabrook ME; Barry EL; Fedirko V; Baron JA; Bostick RM
Mol Carcinog; 2019 Apr; 58(4):511-523. PubMed ID: 30499618
[TBL] [Abstract][Full Text] [Related]
26. [Role of Wnt signaling and APC protein in the etiology of colorectal cancer].
Cebrat M; Strzadała L
Postepy Hig Med Dosw; 2001; 55(4):513-24. PubMed ID: 11766228
[TBL] [Abstract][Full Text] [Related]
27. Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia.
Tanaka S; Imanishi K; Yoshihara M; Haruma K; Sumii K; Kajiyama G; Akamatsu S
Am J Pathol; 1991 Jul; 139(1):123-9. PubMed ID: 1853928
[TBL] [Abstract][Full Text] [Related]
28. Empirical Bayes screening of many p-values with applications to microarray studies.
Datta S; Datta S
Bioinformatics; 2005 May; 21(9):1987-94. PubMed ID: 15691856
[TBL] [Abstract][Full Text] [Related]
29. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma].
Cao YC; Yang F; Liu XH; Xin X; Wang CC; Geng M
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):674-8. PubMed ID: 23159080
[TBL] [Abstract][Full Text] [Related]
30. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
31.
Tanaka N; Mashima T; Mizutani A; Sato A; Aoyama A; Gong B; Yoshida H; Muramatsu Y; Nakata K; Matsuura M; Katayama R; Nagayama S; Fujita N; Sugimoto Y; Seimiya H
Mol Cancer Ther; 2017 Apr; 16(4):752-762. PubMed ID: 28179481
[TBL] [Abstract][Full Text] [Related]
32. Molecular biology of colorectal cancer.
Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
[TBL] [Abstract][Full Text] [Related]
33. APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC.
Schneikert J; Brauburger K; Behrens J
Hum Mol Genet; 2011 Sep; 20(18):3554-64. PubMed ID: 21665989
[TBL] [Abstract][Full Text] [Related]
34. Role of APC and its binding partners in regulating microtubules in mitosis.
Bahmanyar S; Nelson WJ; Barth AI
Adv Exp Med Biol; 2009; 656():65-74. PubMed ID: 19928353
[TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers.
Ghorbanoghli Z; Nieuwenhuis MH; Houwing-Duistermaat JJ; Jagmohan-Changur S; Hes FJ; Tops CM; Wagner A; Aalfs CM; Verhoef S; Gómez García EB; Sijmons RH; Menko FH; Letteboer TG; Hoogerbrugge N; van Wezel T; Vasen HF; Wijnen JT
Fam Cancer; 2016 Oct; 15(4):563-70. PubMed ID: 26880076
[TBL] [Abstract][Full Text] [Related]
36. Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates.
Mahasneh A; Al-Shaheri F; Jamal E
Exp Mol Pathol; 2017 Jun; 102(3):475-483. PubMed ID: 28506769
[TBL] [Abstract][Full Text] [Related]
37. Bayesian variable selection with joint modeling of categorical and survival outcomes: an application to individualizing chemotherapy treatment in advanced colorectal cancer.
Chen W; Ghosh D; Raghunathan TE; Sargent DJ
Biometrics; 2009 Dec; 65(4):1030-40. PubMed ID: 19210736
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer detection by biomarker quantification in noninvasively collected colorectal mucus: preliminary comparison of 24 protein biomarkers.
Loktionov A; Soubieres A; Bandaletova T; Mathur J; Poullis A
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1220-1227. PubMed ID: 31498281
[TBL] [Abstract][Full Text] [Related]
39. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
Kohler EM; Chandra SH; Behrens J; Schneikert J
Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
